Thermo Fisher Scientific (TMO) Gross Margin (2009 - 2026)

Thermo Fisher Scientific has disclosed Gross Margin across 18 years of filings, most recently posting 70.37% for Q1 2026.

• Quarterly Gross Margin rose 52.0% year-over-year to 70.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 71.2% (up 105.0% YoY) and the FY2025 annual result came in at 71.02%, up 53.0% from the prior year.
• Gross Margin eased to 70.37% in Q1 2026, from 73.56% in the prior quarter.
• Over five years, Gross Margin peaked at 73.56% in Q4 2025 and troughed at 65.71% in Q4 2023.
• A 5-year average of 69.94% and a median of 69.92% in 2022 frame the typical range for Gross Margin.
• Biggest YoY gain for Gross Margin was 410 bps in 2022; the steepest drop was 6951 bps in 2022.
• Tracing TMO's Gross Margin over 5 years: stood at 67.84% in 2022, then retreated by 3 bps to 65.71% in 2023, then gained by 6 bps to 69.59% in 2024, then increased by 6 bps to 73.56% in 2025, then slipped by 4 bps to 70.37% in 2026.
• Business Quant data shows TMO's Gross Margin at 70.37% in Q1 2026, 73.56% in Q4 2025, and 70.16% in Q3 2025.